Baicalein Potentiated M1 Macrophage Polarization in Cancer Through Targeting PI3Kγ/ NF-κB Signaling
Baicalein is one of the bioactive compounds extracted from Scutellaria baicalensis . Recent studies indicated the antitumor effects of baicalein, however, the underlying mechanisms are needed to be further determined. In this study, we found that baicalein could inhibit the tumor growth in mice mode...
Saved in:
Published in | Frontiers in pharmacology Vol. 12; p. 743837 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
25.08.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Baicalein is one of the bioactive compounds extracted from
Scutellaria baicalensis
. Recent studies indicated the antitumor effects of baicalein, however, the underlying mechanisms are needed to be further determined. In this study, we found that baicalein could inhibit the tumor growth in mice models of breast cancer and melanoma and worked as an immunomodulator to promote the infiltration of tumor-associated macrophages (TAMs) and skew the TAMs towards the M1-like phenotype. Baicalein also induced M1-like phenotype polarization in THP-1-derived macrophages. Meanwhile, the expression of pro-inflammatory factors associated with M1 macrophages, including TNF-α, IL-1β, CXCL9 and CXCL10, were increased after baicalein treatment. Mechanistically, the RNA-seq data suggested that baicalein potentiated the M1 macrophage polarization
via
the NF-κB/TNF-α signaling pathway. ELISA and confocal microscopy assay confirmed that baicalein significantly induced the production of TNF-α and the activation of NF-κB, while TNF-α neutralization inhibited baicalein-induced macrophage polarization toward M1, and NF-κB P65 knock-down suppressed baicalein-induced TNF-α production in THP-1-derived macrophages. Phosphoinositide 3-kinase (PI3k) γ has been reported as a key molecule in macrophage polarization, and inhibition of PI3Kγ activates the NF-κB-related inflammatory signals. Our pharmacological network analysis predicted that PI3Kγ might be one of the major targets of baicalein. The results from the docking program and surface plasmon resonance (SPR) confirmed that baicalein displayed good binding activity to PI3Kγ. We further found that baicalein not only exhibited a direct inhibitory effect on the protein kinase activity of PI3Kγ, but also reduced the mRNA and protein expression of PI3Kγ, indicating that baicalein might be a novel PI3Kγ inhibitor. In summary, baicalein mediated the TAMs skewing to M1-TAMs, and then retarded tumor growth. These effects, at least in part, were linked to the PI3Kγ/NF-κB signaling. |
---|---|
AbstractList | Baicalein is one of the bioactive compounds extracted from
Scutellaria baicalensis
. Recent studies indicated the antitumor effects of baicalein, however, the underlying mechanisms are needed to be further determined. In this study, we found that baicalein could inhibit the tumor growth in mice models of breast cancer and melanoma and worked as an immunomodulator to promote the infiltration of tumor-associated macrophages (TAMs) and skew the TAMs towards the M1-like phenotype. Baicalein also induced M1-like phenotype polarization in THP-1-derived macrophages. Meanwhile, the expression of pro-inflammatory factors associated with M1 macrophages, including TNF-α, IL-1β, CXCL9 and CXCL10, were increased after baicalein treatment. Mechanistically, the RNA-seq data suggested that baicalein potentiated the M1 macrophage polarization
via
the NF-κB/TNF-α signaling pathway. ELISA and confocal microscopy assay confirmed that baicalein significantly induced the production of TNF-α and the activation of NF-κB, while TNF-α neutralization inhibited baicalein-induced macrophage polarization toward M1, and NF-κB P65 knock-down suppressed baicalein-induced TNF-α production in THP-1-derived macrophages. Phosphoinositide 3-kinase (PI3k) γ has been reported as a key molecule in macrophage polarization, and inhibition of PI3Kγ activates the NF-κB-related inflammatory signals. Our pharmacological network analysis predicted that PI3Kγ might be one of the major targets of baicalein. The results from the docking program and surface plasmon resonance (SPR) confirmed that baicalein displayed good binding activity to PI3Kγ. We further found that baicalein not only exhibited a direct inhibitory effect on the protein kinase activity of PI3Kγ, but also reduced the mRNA and protein expression of PI3Kγ, indicating that baicalein might be a novel PI3Kγ inhibitor. In summary, baicalein mediated the TAMs skewing to M1-TAMs, and then retarded tumor growth. These effects, at least in part, were linked to the PI3Kγ/NF-κB signaling. Baicalein is one of the bioactive compounds extracted from Scutellaria baicalensis. Recent studies indicated the antitumor effects of baicalein, however, the underlying mechanisms are needed to be further determined. In this study, we found that baicalein could inhibit the tumor growth in mice models of breast cancer and melanoma and worked as an immunomodulator to promote the infiltration of tumor-associated macrophages (TAMs) and skew the TAMs towards the M1-like phenotype. Baicalein also induced M1-like phenotype polarization in THP-1-derived macrophages. Meanwhile, the expression of pro-inflammatory factors associated with M1 macrophages, including TNF-α, IL-1β, CXCL9 and CXCL10, were increased after baicalein treatment. Mechanistically, the RNA-seq data suggested that baicalein potentiated the M1 macrophage polarization via the NF-κB/TNF-α signaling pathway. ELISA and confocal microscopy assay confirmed that baicalein significantly induced the production of TNF-α and the activation of NF-κB, while TNF-α neutralization inhibited baicalein-induced macrophage polarization toward M1, and NF-κB P65 knock-down suppressed baicalein-induced TNF-α production in THP-1-derived macrophages. Phosphoinositide 3-kinase (PI3k) γ has been reported as a key molecule in macrophage polarization, and inhibition of PI3Kγ activates the NF-κB-related inflammatory signals. Our pharmacological network analysis predicted that PI3Kγ might be one of the major targets of baicalein. The results from the docking program and surface plasmon resonance (SPR) confirmed that baicalein displayed good binding activity to PI3Kγ. We further found that baicalein not only exhibited a direct inhibitory effect on the protein kinase activity of PI3Kγ, but also reduced the mRNA and protein expression of PI3Kγ, indicating that baicalein might be a novel PI3Kγ inhibitor. In summary, baicalein mediated the TAMs skewing to M1-TAMs, and then retarded tumor growth. These effects, at least in part, were linked to the PI3Kγ/NF-κB signaling. |
Author | Liu, Suqing Li, Zheng He, Shan Wang, Shangshang Liu, Xiao Wu, Jinfeng |
AuthorAffiliation | Department of Dermatology, Huashan Hospital, Fudan University, Shanghai , China |
AuthorAffiliation_xml | – name: Department of Dermatology, Huashan Hospital, Fudan University, Shanghai , China |
Author_xml | – sequence: 1 givenname: Shan surname: He fullname: He, Shan – sequence: 2 givenname: Shangshang surname: Wang fullname: Wang, Shangshang – sequence: 3 givenname: Suqing surname: Liu fullname: Liu, Suqing – sequence: 4 givenname: Zheng surname: Li fullname: Li, Zheng – sequence: 5 givenname: Xiao surname: Liu fullname: Liu, Xiao – sequence: 6 givenname: Jinfeng surname: Wu fullname: Wu, Jinfeng |
BookMark | eNpVkc1uEzEUhS1UREvoA7CbJZuk4397g0QjClFbqERYW3c8dyauJnbwTJDgtdjxEH0m3Kaq6N34yufou9I5r8lRTBEJeUvrBefGnnW7DeQFqxldaMEN1y_ICVWKz62h7Oi__ZicjuNtXYZby5V4RY65kJRxpU8InkPwMGCI1U2aME4BJmyra1pdg8-p3OixKAPk8BumkGJVnEuIHnO13uS07zfVGnKPU4h9dbPil3d_zqovF_O7v-fVt9BHGIrwhrzsYBjx9PGdke8XH9fLz_Orr59Wyw9Xcy8Em-YGNEfFRA2gpBUSaimV8Jx3lnVGiUbSurWs1tbS1jfMMo2m1R6YbprOIJ-R1YHbJrh1uxy2kH-5BME9fKTcO8hT8AM6WcJgRltFOYgWWdNQqb1l3KhWWITCen9g7fbNFltfsskwPIM-V2LYuD79dEYwbkvYM_LuEZDTjz2Ok9uG0eMwQMS0Hx2TmjGqjJXFSg_WEvk4ZuyeztDa3bftHtp29227Q9v8H276nvE |
CitedBy_id | crossref_primary_10_1007_s12272_023_01461_2 crossref_primary_10_1016_j_phymed_2024_155794 crossref_primary_10_1016_j_biopha_2024_116862 crossref_primary_10_3390_s23104831 crossref_primary_10_3390_ijms232415753 crossref_primary_10_1007_s12272_022_01397_z crossref_primary_10_3389_fphar_2022_888054 crossref_primary_10_1016_j_phrs_2022_106419 crossref_primary_10_2174_1568026623666230201145909 crossref_primary_10_2174_1566524023666230320163238 crossref_primary_10_1142_S0192415X23500155 crossref_primary_10_1016_j_intimp_2022_108861 crossref_primary_10_1016_j_biopha_2023_115090 crossref_primary_10_1016_j_intimp_2024_112613 crossref_primary_10_1016_j_lfs_2022_120572 crossref_primary_10_1016_j_prp_2023_154676 crossref_primary_10_1186_s12906_024_04444_y crossref_primary_10_1016_j_jep_2024_118038 crossref_primary_10_1016_j_phrs_2023_107032 crossref_primary_10_1016_j_jep_2023_117183 crossref_primary_10_1016_j_phymed_2024_155684 crossref_primary_10_3390_ijms24032657 crossref_primary_10_1002_cam4_5489 crossref_primary_10_3389_fphar_2023_1242955 crossref_primary_10_1016_j_jare_2024_01_013 crossref_primary_10_3390_genes15020197 crossref_primary_10_1002_mc_23724 |
Cites_doi | 10.1158/1078-0432.CCR-19-1868 10.1016/j.immuni.2014.06.008 10.1186/s40425-019-0568-2 10.18632/oncotarget.9984 10.1126/scitranslmed.aal3604 10.1016/j.biopha.2019.109570 10.12703/P6-13 10.1016/S1471-4906(02)02302-5 10.2147/DDDT.S181939 10.1038/nature19834 10.1007/s12026-012-8349-8 10.1038/ni.2060 10.1158/1078-0432.CCR-16-3122 10.1038/nature20554 10.7150/ijbs.41768 10.3390/ijms17101681 10.1073/pnas.1720948115 10.1016/j.ccell.2015.02.015 10.1371/journal.pone.0206223 10.1016/j.biopha.2017.07.068 10.1038/nrd.2018.169 10.1016/j.biopha.2019.109735 10.1016/j.intimp.2019.105824 10.1186/s40425-019-0610-4 10.1016/j.semcancer.2016.02.001 10.1186/1476-4598-12-86 10.1016/j.apsb.2020.04.004 10.3390/molecules25235677 10.3727/096504018X15399945637736 10.1186/s12943-019-1102-3 10.1111/cas.14577 |
ContentType | Journal Article |
Copyright | Copyright © 2021 He, Wang, Liu, Li, Liu and Wu. 2021 He, Wang, Liu, Li, Liu and Wu |
Copyright_xml | – notice: Copyright © 2021 He, Wang, Liu, Li, Liu and Wu. 2021 He, Wang, Liu, Li, Liu and Wu |
DBID | AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fphar.2021.743837 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | He et al |
EISSN | 1663-9812 |
EndPage | 743837 |
ExternalDocumentID | oai_doaj_org_article_53992879613a4de2bb157c92386d49ea 10_3389_fphar_2021_743837 |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE IAO IEA IHR IHW KQ8 M48 M~E O5R O5S OK1 P2P PGMZT RNS RPM 7X8 ITC 5PM |
ID | FETCH-LOGICAL-c442t-8a73e6240aa65945a05564c33f92f864b510d9207991dcb2927e8d7ca27bbf8e3 |
IEDL.DBID | RPM |
ISSN | 1663-9812 |
IngestDate | Fri Oct 04 13:06:27 EDT 2024 Tue Sep 17 21:23:23 EDT 2024 Fri Aug 16 11:24:02 EDT 2024 Thu Sep 26 19:08:38 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c442t-8a73e6240aa65945a05564c33f92f864b510d9207991dcb2927e8d7ca27bbf8e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Xunwei Wu, Shandong University, China These authors have contributed equally to this work Reviewed by:Cong Peng, Central South University, China Edited by:Tao Xu, Anhui Medical University, China This article was submitted to Inflammation Pharmacology, a section of the journal Frontiers in Pharmacology |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423900/ |
PMID | 34512367 |
PQID | 2572216895 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_53992879613a4de2bb157c92386d49ea pubmedcentral_primary_oai_pubmedcentral_nih_gov_8423900 proquest_miscellaneous_2572216895 crossref_primary_10_3389_fphar_2021_743837 |
PublicationCentury | 2000 |
PublicationDate | 2021-08-25 |
PublicationDateYYYYMMDD | 2021-08-25 |
PublicationDate_xml | – month: 08 year: 2021 text: 2021-08-25 day: 25 |
PublicationDecade | 2020 |
PublicationTitle | Frontiers in pharmacology |
PublicationYear | 2021 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Guo (B9) 2019; 27 Yan (B28) 2018; 12 Yang (B29) 2020; 10 Arlauckas (B1) 2017; 9 De Henau (B7) 2016; 539 House (B12) 2020; 26 Heideveld (B10) 2020 Lee (B15) 2019; 7 Murray (B22) 2014; 41 Wang (B26) 2020; 121 Peranzoni (B24) 2018; 115 Zhao (B33) 2018; 8 Li (B17) 2020; 123 Kaneda (B13) 2016; 539 Hoesel (B11) 2013; 12 Aznar (B2) 2019; 7 Deng (B8) 2020; 16 Mantovani (B19) 2002; 23 Zhang (B32) 2020; 111 Li (B16) 2019; 18 Nik Salleh (B23) 2020; 25 Wu (B27) 2016; 7 Bie (B4) 2017; 93 Martinez (B20) 2014; 6 Cassetta (B6) 2018; 17 McNamee (B21) 2013; 55 Yarla (B30) 2016 Ke (B14) 2019; 75 Liu (B18) 2016; 17 Yu (B31) 2018; 13 Brown (B5) 2017; 23 Ben-Neriah (B3) 2011; 12 Ruffell (B25) 2015; 27 |
References_xml | – volume: 26 start-page: 487 year: 2020 ident: B12 article-title: Macrophage-derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-19-1868 contributor: fullname: House – volume: 41 start-page: 14 year: 2014 ident: B22 article-title: Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines publication-title: Immunity doi: 10.1016/j.immuni.2014.06.008 contributor: fullname: Murray – volume: 7 start-page: 116 year: 2019 ident: B2 article-title: Immunotherapeutic Effects of Intratumoral Nanoplexed Poly I:C publication-title: J. Immunother. Cancer doi: 10.1186/s40425-019-0568-2 contributor: fullname: Aznar – volume: 7 start-page: 51251 year: 2016 ident: B27 article-title: Iciartin, a Novel FASN Inhibitor, Exerts Anti-melanoma Activities through IGF-1R/STAT3 Signaling publication-title: Oncotarget doi: 10.18632/oncotarget.9984 contributor: fullname: Wu – volume: 9 start-page: eaal3604 year: 2017 ident: B1 article-title: In Vivo imaging Reveals a Tumor-Associated Macrophage-Mediated Resistance Pathway in Anti-PD-1 Therapy publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aal3604 contributor: fullname: Arlauckas – volume: 121 start-page: 109570 year: 2020 ident: B26 article-title: Antitumor Effects of Immunity-Enhancing Traditional Chinese Medicine publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2019.109570 contributor: fullname: Wang – volume: 6 start-page: 13 year: 2014 ident: B20 article-title: The M1 and M2 Paradigm of Macrophage Activation: Time for Reassessment publication-title: F1000prime Rep. doi: 10.12703/P6-13 contributor: fullname: Martinez – volume: 23 start-page: 549 year: 2002 ident: B19 article-title: Macrophage Polarization: Tumor-Associated Macrophages as a Paradigm for Polarized M2 Mononuclear Phagocytes publication-title: Trends Immunol. doi: 10.1016/S1471-4906(02)02302-5 contributor: fullname: Mantovani – volume: 12 start-page: 3961 year: 2018 ident: B28 article-title: Baicalein Induces Apoptosis and Autophagy of Breast Cancer Cells via Inhibiting PI3K/AKT Pathway In Vivo and Vitro publication-title: Drug Des. Devel. Ther. doi: 10.2147/DDDT.S181939 contributor: fullname: Yan – volume: 8 start-page: 1528 year: 2018 ident: B33 article-title: Baicalein Suppress EMT of Breast Cancer by Mediating Tumor-Associated Macrophages Polarization publication-title: Am. J. Cancer Res. contributor: fullname: Zhao – volume: 539 start-page: 437 year: 2016 ident: B13 article-title: PI3Kγ Is a Molecular Switch that Controls Immune Suppression publication-title: Nature doi: 10.1038/nature19834 contributor: fullname: Kaneda – volume: 55 start-page: 58 year: 2013 ident: B21 article-title: Hypoxia and Hypoxia-Inducible Factors as Regulators of T Cell Development, Differentiation, and Function publication-title: Immunol. Res. doi: 10.1007/s12026-012-8349-8 contributor: fullname: McNamee – volume: 12 start-page: 715 year: 2011 ident: B3 article-title: Inflammation Meets Cancer, with NF-κB as the Matchmaker publication-title: Nat. Immunol. doi: 10.1038/ni.2060 contributor: fullname: Ben-Neriah – volume: 23 start-page: 3241 year: 2017 ident: B5 article-title: The Promise of Targeting Macrophages in Cancer Therapy publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-16-3122 contributor: fullname: Brown – volume: 539 start-page: 443 year: 2016 ident: B7 article-title: Overcoming Resistance to Checkpoint Blockade Therapy by Targeting PI3Kγ in Myeloid Cells publication-title: Nature doi: 10.1038/nature20554 contributor: fullname: De Henau – volume: 16 start-page: 1403 year: 2020 ident: B8 article-title: Drp1-mediated Mitochondrial Fission Contributes to Baicalein-Induced Apoptosis and Autophagy in Lung Cancer via Activation of AMPK Signaling Pathway publication-title: Int. J. Biol. Sci. doi: 10.7150/ijbs.41768 contributor: fullname: Deng – volume: 17 start-page: 1681 year: 2016 ident: B18 article-title: The Fascinating Effects of Baicalein on Cancer: A Review publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms17101681 contributor: fullname: Liu – volume: 115 start-page: E4041 year: 2018 ident: B24 article-title: Macrophages Impede CD8 T Cells from Reaching Tumor Cells and Limit the Efficacy of Anti-PD-1 Treatment publication-title: Proc. Natl. Acad. Sci. U S A. doi: 10.1073/pnas.1720948115 contributor: fullname: Peranzoni – volume: 27 start-page: 462 year: 2015 ident: B25 article-title: Macrophages and Therapeutic Resistance in Cancer publication-title: Cancer Cell doi: 10.1016/j.ccell.2015.02.015 contributor: fullname: Ruffell – volume: 13 start-page: e0206223 year: 2018 ident: B31 article-title: Tumor-immune Profiling of Murine Syngeneic Tumor Models as a Framework to Guide Mechanistic Studies and Predict Therapy Response in Distinct Tumor Microenvironments publication-title: PLoS One doi: 10.1371/journal.pone.0206223 contributor: fullname: Yu – volume: 93 start-page: 1285 year: 2017 ident: B4 article-title: Baicalein: A Review of its Anti-cancer Effects and Mechanisms in Hepatocellular Carcinoma publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2017.07.068 contributor: fullname: Bie – volume: 17 start-page: 887 year: 2018 ident: B6 article-title: Targeting Macrophages: Therapeutic Approaches in Cancer publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd.2018.169 contributor: fullname: Cassetta – volume: 123 start-page: 109735 year: 2020 ident: B17 article-title: Bu-Shen-Fang-Chuan Formula Attenuates T-Lymphocytes Recruitment in the Lung of Rats with COPD through Suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2019.109735 contributor: fullname: Li – volume: 75 start-page: 105824 year: 2019 ident: B14 article-title: Baicalein and Baicalin Promote Antitumor Immunity by Suppressing PD-L1 Expression in Hepatocellular Carcinoma Cells publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2019.105824 contributor: fullname: Ke – volume: 7 start-page: 147 year: 2019 ident: B15 article-title: Targeting of M2-like Tumor-Associated Macrophages with a Melittin-Based Pro-apoptotic Peptide publication-title: J. Immunother. Cancer doi: 10.1186/s40425-019-0610-4 contributor: fullname: Lee – start-page: 48 year: 2016 ident: B30 article-title: Targeting Arachidonic Acid Pathway by Natural Products for Cancer Prevention and Therapy publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2016.02.001 contributor: fullname: Yarla – volume: 12 start-page: 86 year: 2013 ident: B11 article-title: The Complexity of NF-κB Signaling in Inflammation and Cancer publication-title: Mol. Cancer doi: 10.1186/1476-4598-12-86 contributor: fullname: Hoesel – volume: 10 start-page: 2156 year: 2020 ident: B29 article-title: The Role of Tumor-Associated Macrophages (TAMs) in Tumor Progression and Relevant advance in Targeted Therapy publication-title: Acta Pharm. Sin. B doi: 10.1016/j.apsb.2020.04.004 contributor: fullname: Yang – start-page: 113 volume-title: Methods Enzymol. year: 2020 ident: B10 article-title: Methods for Macrophage Differentiation and in Vitro Generation of Human Tumor Associated-like Macrophages contributor: fullname: Heideveld – volume: 25 start-page: 5677 year: 2020 ident: B23 article-title: The Biological Activities and Therapeutic Potentials of Baicalein Extracted from Oroxylum Indicum: A Systematic Review publication-title: Molecules doi: 10.3390/molecules25235677 contributor: fullname: Nik Salleh – volume: 27 start-page: 601 year: 2019 ident: B9 article-title: Baicalein Exerts Anticancer Effect in Nasopharyngeal Carcinoma In Vitro and In Vivo publication-title: Oncol. Res. doi: 10.3727/096504018X15399945637736 contributor: fullname: Guo – volume: 18 start-page: 177 year: 2019 ident: B16 article-title: Harnessing Tumor-Associated Macrophages as Aids for Cancer Immunotherapy publication-title: Mol. Cancer doi: 10.1186/s12943-019-1102-3 contributor: fullname: Li – volume: 111 start-page: 3802 year: 2020 ident: B32 article-title: Baicalein Inhibits Non-small-cell Lung Cancer Invasion and Metastasis by Reducing Ezrin Tension in Inflammation Microenvironment publication-title: Cancer Sci. doi: 10.1111/cas.14577 contributor: fullname: Zhang |
SSID | ssj0000399364 |
Score | 2.4340026 |
Snippet | Baicalein is one of the bioactive compounds extracted from
Scutellaria baicalensis
. Recent studies indicated the antitumor effects of baicalein, however, the... Baicalein is one of the bioactive compounds extracted from Scutellaria baicalensis. Recent studies indicated the antitumor effects of baicalein, however, the... |
SourceID | doaj pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database |
StartPage | 743837 |
SubjectTerms | baicalein NF-k B Pharmacology PI3Kγ polarization tumor-associated macrophages |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NTtwwELYQp15QS6m6FCpXQhwQ6SaOf49d1BU_Aq3UReJm2Y7N7iWLYDnwXL31IXimzjhL2Zy49JJD7DiOv7FnJh5_Q8iB0Mz7aKoieVEWXMVU-NqHwiS4cp50CjlA9kqeXvPzG3GzluoLY8I6euBu4IaZOVUrA2rH8SZCy5VQAcwSLRtuYmcaVWLNmcprMOpdybttTPDCzDDdzRzyf7Lqu0J6TtVTRJmvv2dk9kMk13TO-D3ZWhmL9EfXyQ9kI7bb5HDSsU0_HdPp6-Gph2N6SCevPNRPH0kcOUQgzls6WSwxKgjsyoZeVvTSYeKuGSwlUAKu7eosJoWaJygF99ByTt9DpzlQHNQbnZzVF8-_h_RqXDz_GdFf81s04dvbHXI9_jk9OS1WWRUKGHu2LLRTdZSgyJ2TwnDhkE6Hh7pOhiUtuYdZ2hhWKrAcm-CZYSrqRgXHlPdJx_oT2WwXbfxMqCyDrmIQJgaGNDXwtKy9a0qVDHinfECOXobY3nXkGRacDsTDZjws4mE7PAZkhCD8q4i81_kGSINdSYN9SxoG5NsLhBbmCW5-uDYuHh8sLE2MVVIbMSCqh23vjf2Sdj7LjNsaaRLLcvd_dPELeYdfjf-lmdgjm8v7x7gPhs3Sf80y_Beu7fhD priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pb9MwFLbGuHBBMEAUBjIS2gEtW-I4_nGYEJ2oBqhTJVppN8tO7LYSSre2k-jfxW1_xP4m3nPSjUg7cskhsfPD37Pf92L7e4R8LBRzzussCa5IEy59SFzuykQHOHIeVCjjAtlzcTbh3y-Kix2yTW_VNuDqwdAO80lNlr-Ofl9tPkOHP8GIE_ztcbicWZT2ZNmRROVN-Yg8ZjznaPDDlu3HgRmdseDN3ObDNTveKYr4d5hnd93kP45o8Iw8bRkk_dJA_pzs-HqPHIwaCerNIR3f76haHdIDOroXp968IL5vERY_r-loscalQkA2KzrM6NBiNq8ZjC9wBRql3aBJoeQpmsYS7hxz-tBxXD0OPo-OvuU_bv8c0_NBcnvTpz_nU-T19fQlmQy-jk_PkjbVQgKAsHWirMy9AO9urSg0Lyxq7PAyz4NmQQnuoOtWmqUS6GRVOqaZ9KqSpWXSuaB8_ors1ovavyZUpKXKfFloXzLUroHaIne2SmXQELLyHvm0bWJz2ShqGIhEEA8T8TCIh2nw6JE-gnBXEMWw44nFcmravmWiuK6SGpiJ5ZUH48sKWQJzVaLi2tse-bCF0EDnwRkRW_vF9crAeMVYJpQuekR2sO08sXulns-iDLdC7cQ0ffM_XvEteYJfjT-rWbFPdtfLa_8O2M7avY82_BdYiwEn priority: 102 providerName: Scholars Portal |
Title | Baicalein Potentiated M1 Macrophage Polarization in Cancer Through Targeting PI3Kγ/ NF-κB Signaling |
URI | https://search.proquest.com/docview/2572216895 https://pubmed.ncbi.nlm.nih.gov/PMC8423900 https://doaj.org/article/53992879613a4de2bb157c92386d49ea |
Volume | 12 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07b9swECaSTF2Kpg_UbRIwQJGhiCyJD5EcayNG2sKBgDpANoGkSNtAIxuOM-R3ZeuPyG_qkZKbaO3CQST1-o68O_L4HUJfuCTGOJUn3vAsYcL5xFBjE-WhZMxLb2OA7FVxec1-3PCbPcR3Z2Fi0L41y2Hz-3bYLBcxtnJ9a9NdnFhaTscysNZlWbqP9gWlL1z0OP0GlVuwdgcTHDCV-vVCB-pPkg9FYOYMifco45G8rKeOImt_z9TsB0q-0DyTN-h1ZzLib-2rHaI917xFZ2XLOf1wjmfPR6juzvEZLp_ZqB_eITfSAQe3bHC52obYILAuazzN8VSH9F0LmFCgBhzc7kQmhpbjIAsbuHNM4oNnMVwclBwuv9OfT48pvpokT39G-NdyHgz5Zv4eXU8uZuPLpMutkAACZJtILagrQJ1rXXDFuA6kOsxS6hXxsmAGxmqtSCbAfqytIYoIJ2thNRHGeOnoB3TQrBr3EeEiszJ3litnSSCrgd4FNbrOhFfgo7IB-rr7xdW6pdCowPUI0FQRmipAU7XQDNAogPCvYWC_jhdWm3nVyUAV2XSlUGCKaFY7kLacCwumqixqppweoNMdhBWMlrAFohu3ur-rYIIiJC-k4gMketj2ntivATGMvNud2H36756f0avwqWFJmvAjdLDd3LtjsGm25iSuBUA5ZfIkyvNfKJ77Xg |
link.rule.ids | 230,315,733,786,790,870,891,2115,24346,27957,27958,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9MwGLbGOMCFb7TyaSS0A1q-HCe2j7Si6thaRaJDu0W247QVLK269DD-Fjd-xH4Tr52ELdzgkkNsJ7Ge1-9H_Pp5EXqfcKKUEZFXqiT0KDOlp2KlPVHCldKSl9olyM7SyRn9fJ6c76GkOwvjkva1WvnV9wu_Wi1dbuXmQgddnliQTUfcstaFYXAH3YX1StitIN0pYGt0U9rsYUIIJoJys5SW_JNEPrPcnLb0XkwTR1_WM0iOt7_nbPZTJW_ZnvFD9LX76ibl5Ju_q5Wvf_xF6PjP03qEHrTeKP7YND9Ge6Z6gg6zhs766gjPb05nXR7hQ5zdEF1fPUVmKC3EZlXhbF3btCNwXAs8jfBU2spgS9BV0AKxc3vYE0PPkRWzLTzZ1QfCc5eJDvYTZ8fxyfXPAM_G3vWvIf6yWtgYoVo8Q2fjT_PRxGvLNngALqk9LllsUvAUpEwTQRNp-XqojuNSkJKnVIEaKAQJGbimhVZEEGZ4wbQkTKmSm_g52q_WlTlAOA01j4xOhNHE8uDA6DRWsghZKSD8pQP0ocMu3zTsHDlENRbz3GGeW8zzBvMBGlp0_3S0xNruxnq7yFscckfUy5kAL0fSwoAgRwnT4AXztKDCyAF618lGDgvR7q7Iyqx3lznoPkKilItkgFhPaHpv7LeAKDhK7xb6F_898i26N5lPT_PT49nJS3TfTtv--Y74K7Rfb3fmNbhOtXrjFspvtmEbkg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9MwGLZgSIgL34hufBgJ7YCWJnGc2D7SQrUxWkWikyYuke3YbQVLqy49jL_FjR-x38RrJ2UNx11yiO0k1vP6_YhfPy9C71NOlDIiDqxKo4AyYwOVKB0IC1dKLbfaJ8hOsuMz-uU8Pd8p9eWT9rVa9KufF_1qMfe5lasLHW7zxMJ8POSOtS6KwlVpw7voHqxZInYCda-EneHNaLOPCWGYCO1qLh0BKIn7zPFzuvJ7CU09hVnHKHnu_o7D2U2X3LE_o0fo-_bLm7STH_1Nrfr613-kjrea2mP0sPVK8cemyxN0x1RP0WHe0FpfHeHpzSmtyyN8iPMbwuurZ8gMpIPaLCqcL2uXfgQObInHMR5LVyFsDjoLWiCGbg99Yug5dOK2hif7OkF46jPSwY7i_CQ5vf4d4skouP4zwN8WMxcrVLPn6Gz0eTo8DtryDQGATOqAS5aYDDwGKbNU0FQ63h6qk8QKYnlGFaiDUpCIgYtaakUEYYaXTEvClLLcJC_QXrWszEuEs0jz2OhUGE0cHw6MzhIly4hZAWEw7aEPW_yKVcPSUUB043AvPO6Fw71ocO-hgUP4X0dHsO1vLNezosWi8IS9nAnwdiQtDQh0nDIN3jDPSiqM7KF3W_koYEG6XRZZmeXmsgAdSEiccZH2EOsITueN3RYQB0_t3cK_f-uRb9H9_NOo-HoyOT1AD9ys3Q9wkr5Ce_V6Y16DB1WrN36t_AWIoR4Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Baicalein+Potentiated+M1+Macrophage+Polarization+in+Cancer+Through+Targeting+PI3K%CE%B3%2F+NF-%CE%BAB+Signaling&rft.jtitle=Frontiers+in+pharmacology&rft.au=Shan+He&rft.au=Shangshang+Wang&rft.au=Suqing+Liu&rft.au=Zheng+Li&rft.date=2021-08-25&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-9812&rft.volume=12&rft_id=info:doi/10.3389%2Ffphar.2021.743837&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_53992879613a4de2bb157c92386d49ea |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon |